Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

Azenta, Inc.

Filed: Feb 5, 2026 CIK: 0000933974
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Azenta faces significant internal control deficiencies with material weaknesses in financial reporting that require remediation. The company is undergoing business transformation initiatives while managing divestiture impacts from the B Medical Systems sale, creating operational complexity during a period of internal control vulnerabilities.

Red Flags Detected (5)

Material weaknesses in internal control over financial reporting

Ongoing remediation efforts for control deficiencies

Business transformation initiatives during control weakness period

2 more red flags detected

Key Takeaways

Company has identified and is addressing material internal control weaknesses

Active business transformation and cost-saving initiatives underway

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateFeb 5, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence85%
Red Flags5

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings